Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ilke Akpinar"'
Autor:
Dat T Tran, Ilke Akpinar, Richard Fedorak, Egon Jonsson, John Mackey, Lawrence Richer, Philip Jacobs
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 20, Iss 1 (2018)
Purpose: In pharmaceutical clinical trials, industrial sponsors pay for study drugs and related healthcare services. We conducted a study to determine industry’s economic contribution of these trials to the Alberta healthcare system. Methods: We us
Externí odkaz:
https://doaj.org/article/a296d4aed0a443c0b4247e96690f947e
Autor:
Charles Yan, Jeff Round, Ilke Akpinar, Chantal E. Atwood, Lesly Deuchar, Mohit Bhutani, Richard Leigh, Michael K. Stickland
Publikováno v:
PharmacoEconomics - Open. 7:493-505
Many publicly funded health systems use a mix of privately and publicly operated providers of care to deliver elective surgical services. We review the role of private elective surgical provision within publicly funded health systems in high-income c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ee3600ed299681dac91bc0755609ff
https://doi.org/10.21203/rs.3.rs-958399/v1
https://doi.org/10.21203/rs.3.rs-958399/v1
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:2245-2256
Objectives To describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada. Methods We linked Alberta health databases to identify patients aged ≥35 years with inci
Publikováno v:
PharmacoEconomics Open
Objective The objective of this study was to estimate the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. Methods We used the Aggregate Analysis of ClinicalTrials.gov (AACT) database, and included all indus
Autor:
Ilke Akpinar, Philip Jacobs, Richard N. Fedorak, Lawrence Richer, Lars Thording, Arto Ohinmaa, Dat T. Tran
Publikováno v:
PharmacoEconomics Open
Objective Our objective was to describe the costs of industry-sponsored clinical trials for medical devices in Northern Alberta, Canada. Methods We used centralized data to identify all industry-sponsored medical device clinical trials initiated in N
Publikováno v:
Healthcare Management Forum. 32:323-325
Clinical research is funded by industry, governments, charities, and hospitals. It is important to know the economic commitment of the various funding bodies, but until now there has been no national source available which provides these data. We sur
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Objectives To describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada. Methods We linked Alberta health databases to identify patients aged ≥35 years with inci
Autor:
Lawrence Richer, Ilke Akpinar, Philip Jacobs, Egon Jonsson, Dat T. Tran, Richard N. Fedorak, John R. Mackey
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 20, Iss 1 (2018)
Purpose: In pharmaceutical clinical trials, industrial sponsors pay for study drugs and related healthcare services. We conducted a study to determine industry’s economic contribution of these trials to the Alberta healthcare system. Methods: We us
Autor:
Tom Wong, Ilke Akpinar, Philip Jacobs, Ron Read, Nguyen Xuan Thanh, Ameeta E. Singh, Petra Smyczek, Jennifer Gratrix, Sabrina S. Plitt
Publikováno v:
International journal of STDAIDS. 28(13)
Adding universal rectal screening to urogenital screening should positively impact rectal Chlamydia trachomatis (CT) incidence in affected populations. A dynamic Markov model was used to evaluate costs and outcomes of three rectal CT screening strate